Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
Simon Dujardin, Caitlin Commins, Aurélien Lathuilière, Pieter Beerepoot, Analiese R. Fernandes, Tarun Kamath, Mark B. De Los Santos, Naomi Klickstein, Diana L. Corjuc, Bianca T. Corjuc, Patrick M. Dooley, Arthur Viodé, Derek H. Oakley, Ben D. Moore, Kristina Mullin, Dinorah Jean-Gilles, Ryan Clark, Kevin Atchison, Renée Moore, Lori B. Chibnik, Rudolph E. Tanzi, Matthew P. Frosch, Alberto Serrano‐Pozo, Fiona Elwood, Judith A. Steen, Matthew Kennedy, Bradley T. Hyman
Topics & Concepts
Diversity (politics)DiseaseAlzheimer's diseaseNeuroscienceMedicineBiologyGerontologyComputational biologyInternal medicineSociologyAnthropologyAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesComputational Drug Discovery Methods